Pharma

Jubiliant Life gets ANDA approval for its hypertension drug

Jubiliant Life Sciences Ltd has received the final Abbreviated New Drug Application (ANDA) approval for its drug Olmesartan Medoxomil, the generic version...

1.7K

India to impose anti-dumping duty on Amoxycillin from China

The Directorate General of Anti-dumping and Allied Duties (DGAD) has recommended imposition of anti-dumping duty on the import of Amoxycillin, a semi-synthetic...

2.6K

Aurobindo Pharma’s API expansion to create 600 new jobs

Leading Indian pharmaceutical research company Aurobindo Pharma is planning to expand its Active Pharmaceuticals Ingredients (API) manufacturing capacity, providing direct job opportunity...

2.3K

USFDA nod to Aurobindo Pharma for manufacturing HIV drug

Hyderabad-based pharmaceutical major Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to make abacavir sulfate and...

2.9K

Haryana notifies AYUSH Medicine Procurement policy

Chandigarh March 20: With an aim to provide uninterrupted supply of good quality AYUSH medicines free of cost through government hospitals, the...

2.2K

Govt to develop e-platform to regulate sale of drugs

In an effort to plug in the gaps in the sale of drugs in the country, including online sales, the Ministry of...

3.1K

NPPA to regulate price of 14 more medical devices

The National Pharmaceutical Pricing Authority (NPPA) has started scrutinising more medical devices that it says are being sold at inflated rates in...

2.8K

Union Budget 2017-18: New All India Institutes of Medical Sciences to be set-up in Jharkhand and Gujarat

The Union Minister for Finance and Corporate Affairs, Arun Jaitley while presenting the General Budget 2017-18 in Parliament today said that the...

2.2K

Moody’s affirms J&J’s Aaa rating

Moody’s Investors Service affirmed the ratings of Johnson & Johnson including the Aaa senior unsecured rating and the Prime-1 commercial paper rating....